Date | Title | Description | Source |
16.04.2024 | Innovent Announces the Appointment of Dr. Nageatte Ibrahim a... | SAN FRANCISCO and SUZHOU, China, April 16, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Inno... | en.prnasia... |
08.04.2024 | Innovent to Present Preclinical Data of Multiple Novel Molec... | ROCKVILLE, Md. and SUZHOU, China, April 8, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Inno... | en.prnasia... |
02.04.2024 | Innovent and HUTCHMED Jointly Announce NDA Acceptance in Chi... | ROCKVILLE, Md. and SUZHOU, China, April 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Inno... | en.prnasia... |
20.03.2024 | Innovent Announces 2023 Annual Results and Business Updates | A transformative year of strong performance and material innovation progress
ROCKVILLE, M.D. and SUZ... | en.prnasia... |
19.03.2024 | Innovent Announces Primary Endpoint Met in the Second Phase ... | ROCKVILLIE, Md. and SUZHOU, China, March 19, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("In... | en.prnasia... |
12.03.2024 | Innovent to Present Preclinical Data of Multiple Novel Molec... | ROCKVILLE, Md. and SUZHOU, China, March 12, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Inn... | en.prnasia... |
23.05.2019 | MIT researcher alleged to have copied antibody research Otsu... | In an email, sent through a spokesperson, Sasisekharan denied the allegations and wrote that he has ... | medcitynew... |
21.09.2018 | Mithril Capital Management, cofounded by Ajay Royan and Pete... | From its glass-lined offices in San Francisco’s leafy Presidio national park, six-year-old Mithril C... | techcrunch... |
23.10.2017 | With a pipeline from Gerngross’ Adimab, Arsanis hunts a $... | After burning through slightly more than $81 million, a biotech co-founded by Adimab’s Tillman... | endpts.com... |
19.01.2017 | Mithril, Led by Peter Thiel and Ajay Royan, Closes on Roughl... | Peter Thiel being suddenly cast into the center of U.S. politics in 2016 isn’t something that either... | techcrunch... |
04.04.2016 | Peter Thiel firm Mithril Capital Management raises $600M | Promoted
Clinical Care Capacity Planning
Learn how to manage clinical care capacity more efficiently... | medcitynew... |
01.04.2016 | Peter Thiel’s other fund, Mithril Capital Management, raises... | Peter Thiel is having a good month.
According to a new SEC filing, low-flying Mithril Capital Manage... | techcrunch... |
07.01.2016 | Alector gets $29.5M for monoclonal antibody approach to Alzh... | CEO Arnon Rosenthal told MedCity News of this financing in the fall, saying that Alector’s unique ap... | medcitynew... |
16.09.2015 | Alector raises $32M for immunotherapy approach to Alzheimer’... | “We are a hypothesis-driven company,” Rosenthal explained in a phone interview with MedCity News.
Al... | medcitynew... |
06.08.2015 | Avitide nets $7.5M for its next-gen biologics manufacturing ... | The technology was spun out from Dartmouth College in 2013, and is chaired by storied biotech busine... | medcitynew... |
08.07.2015 | Cambridge-based Compass Therapeutics raising $120M for antib... | On its LinkedIn page, Compass Therapeutics bills itself as an antibody discovery and development com... | medcitynew... |
10.03.2014 | J&J takes an early interest in biotech startup Alector’s... | That’s a bit of a different approach than some of the so-called disease-modifying therapies that hav... | medcitynew... |
26.04.2013 | Google Ventures is betting its money on these 8 healthcare a... | DNAnexus The bioinformatics company that provides DNA data management and analysis for sequencing ce... | medcitynew... |
02.04.2012 | Adimab Closes Series F Financing | Adimab, LLC, a Lebanon, NH-based company that discovers fully human antibodies, has closed an over-s... | finsmes.co... |
18.10.2011 | Google Ventures Takes A Moneyball Approach To Investing: It’... | Today at Web 2.0, John Batelle sat down with Bill Maris and Graham Spencer of Google Ventures for a ... | techcrunch... |
03.05.2010 | What Google Ventures wants to fund | Its 11 portfolio companies suggest Google is targetting data analysis and Adsense clones.
Google Ven... | vator.tv/n... |
03.05.2010 | Google Ventures Pulls Back the Veil: Deals in San Diego, Bos... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Just over two years ago, Google dec... | xconomy.co... |
25.03.2008 | Life-science briefing: Tuesday, March 25, 2008 | TODAY’S HEADLINES:
Antibody-discovery startup Adimab raises new funding (release)
Lung-device maker ... | venturebea... |
11.01.2008 | Alder Bio and its yeast-produced antibodies take in $40M | Alder Biopharmaceuticals, a Bothell, Wash., developer of antibody drugs, raised $40 million in a thi... | venturebea... |
20.07.2007 | Adimab: A potential one-stop shop for antibodies | Adimab, a Lebanon, N.H., biotech startup developing a “platform” for the discovery and commercializa... | venturebea... |
- | MIT researcher alleged to have copied antibody research Otsu... | Last year, Japanese drugmaker Otsuka Pharmaceutical paid $430 million to acquire Waltham, Massachuse... | medcitynew... |
- | Alector raises $32M for immunotherapy approach to Alzheimer’... | San Francisco immunotherapy startup Alector just raised $32 million in a Series C round to build out... | medcitynew... |
- | Cambridge-based Compass Therapeutics raising $120M for antib... | Looks as though a new Cambridge startup in the space of antibody drug development is revving up to m... | medcitynew... |
- | Peter Thiel firm Mithril Capital Management raises $600M | Mithril Capital Management, the Peter Thiel-backed venture firm that draws its name from Lord of the... | medcitynew... |
- | Google Ventures is betting its money on these 8 healthcare a... | Google Ventures has been backing startups through its venture capital fund since 2009 and offers a p... | medcitynew... |
- | J&J takes an early interest in biotech startup Alector’s... | In another move to potentially beef up its Alzheimer’s pipeline, Johnson & Johnson has struck a ... | medcitynew... |
- | Avitide nets $7.5M for its next-gen biologics manufacturing ... | New Hampshire biotech Avitide is building out a lithe platform that could turn biologics manufacturi... | medcitynew... |
- | Alector gets $29.5M for monoclonal antibody approach to Alzh... | San Francisco-based biotech Alector just brought in yet another chunk of cash to fund its monoclonal... | medcitynew... |